Terms and concepts: Difference between revisions
Make the 2025 medico-pharmaceutical law book discoverable |
Add complete multilingual reference and language navigation |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
<div class="wiki-language-nav" style="padding:0.75em; border:1px solid #b5c8cd; border-radius:0.5em; margin-bottom:1em;">[[Terms and concepts|English]] · [[Terms and concepts/uk|Українська]] · [[Terms and concepts/es|Español]] · [[Terms and concepts/fr|Français]] · [[Terms and concepts/de|Deutsch]] · [[Terms and concepts/pt|Português]]</div> | |||
This index connects explanatory articles with the books and journal research from which this wiki is developing. It distinguishes general fields of study, source-specific analytical tools and proposals developed in [[Vision 2035]]. | This index connects explanatory articles with the books and journal research from which this wiki is developing. It distinguishes general fields of study, source-specific analytical tools and proposals developed in [[Vision 2035]]. | ||
== Law, medicines and professional practice == | == Law, medicines and professional practice == | ||
* [[Medical law]] | * [[Medical law]]: healthcare rights, responsibilities and accountability. | ||
* [[Pharmaceutical law]] | * [[Pharmaceutical law]]: medicines and pharmaceutical activities. | ||
* [[Medico-pharmaceutical law]] | * [[Medico-pharmaceutical law]]: an integrated approach developed in the research programme. | ||
* '''[[The Concept of Medico-Pharmaceutical Law: Principles, Advantages and Risks of Integration]]''' (2025): the monograph developing the integrated approach. [https://books.sreif.us/index.php/sreif/catalog/book/10 Read the book / publisher record]. | * '''[[The Concept of Medico-Pharmaceutical Law: Principles, Advantages and Risks of Integration]]''' (2025): the monograph developing the integrated approach. [https://books.sreif.us/index.php/sreif/catalog/book/10 Read the book / publisher record]. | ||
* [[Medicines control regime]] | * [[Medicines control regime]]: the relationship of pharmacological and legal classifications. | ||
* [[Safe self-medication]] | * [[Safe self-medication]]: safeguards, professional support and the limits of non-prescription medicine use. | ||
* [[Pharmaceutical law in safe self-medication]] — the 1998, 2005 and 2010 book lineage. | * [[Pharmaceutical law in safe self-medication]] — the 1998, 2005 and 2010 book lineage. | ||
| Line 29: | Line 30: | ||
For article-level sources and starting dates of each journal, see [[Journal research map]]. This is a growing reference index, not an exhaustive dictionary or a substitute for current legal and clinical advice. | For article-level sources and starting dates of each journal, see [[Journal research map]]. This is a growing reference index, not an exhaustive dictionary or a substitute for current legal and clinical advice. | ||
[[Category:Reference indexes]] | [[Category:Reference indexes]] | ||
== Historical reading == | |||
[[Research before 2021]] and [[ORCID bibliography before 2021]] connect the terms above to earlier work on quality, regulation, access, professional duties, compounding and public health. | |||
Latest revision as of 00:52, 12 November 2026
This index connects explanatory articles with the books and journal research from which this wiki is developing. It distinguishes general fields of study, source-specific analytical tools and proposals developed in Vision 2035.
Law, medicines and professional practice
- Medical law: healthcare rights, responsibilities and accountability.
- Pharmaceutical law: medicines and pharmaceutical activities.
- Medico-pharmaceutical law: an integrated approach developed in the research programme.
- The Concept of Medico-Pharmaceutical Law: Principles, Advantages and Risks of Integration (2025): the monograph developing the integrated approach. Read the book / publisher record.
- Medicines control regime: the relationship of pharmacological and legal classifications.
- Safe self-medication: safeguards, professional support and the limits of non-prescription medicine use.
- Pharmaceutical law in safe self-medication — the 1998, 2005 and 2010 book lineage.
Research, quality and access
- Pharmacopoeial standards: testing standards and quality infrastructure.
- Pharmacoeconomic analysis: resource use and pharmaceutical-management analysis.
- Access to medicines: availability and the conditions of obtaining appropriate care.
- Continuity of pharmaceutical supply: legal and organizational resilience during disruption.
- Organizational and legal analysis: connecting rules with professional and institutional activity.
Economics, education and public administration
- State support and economic resilience: distinct support mechanisms during disruption.
- Professional qualification structure: distributions of occupations and qualifications.
- Digital competences and employment policy: education, adaptation and policy proposals.
Intellectual contribution and conceptual development
- US copyright registration: the 2025 monograph, its registration and the distinction from a patent.
- Evolving Authorship: a proposed account of contributions across versions.
- Recipra, All-Being Security and Vision 2035: separately documented conceptual developments.
For article-level sources and starting dates of each journal, see Journal research map. This is a growing reference index, not an exhaustive dictionary or a substitute for current legal and clinical advice.
Historical reading
Research before 2021 and ORCID bibliography before 2021 connect the terms above to earlier work on quality, regulation, access, professional duties, compounding and public health.